{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T08:50:40Z","timestamp":1772787040888,"version":"3.50.1"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"suppl_5","license":[{"start":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T00:00:00Z","timestamp":1475452800000},"content-version":"vor","delay-in-days":329,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/igo\/legalcode"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008309","name":"Johns Hopkins Bloomberg School of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008309","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11,15]]},"DOI":"10.1093\/cid\/civ497","type":"journal-article","created":{"date-parts":[[2015,11,9]],"date-time":"2015-11-09T19:33:10Z","timestamp":1447097590000},"page":"S493-S500","source":"Crossref","is-referenced-by-count":14,"title":["Active Surveillance for Adverse Events After a Mass Vaccination Campaign With a Group A Meningococcal Conjugate Vaccine (PsA-TT) in Mali"],"prefix":"10.1093","volume":"61","author":[{"given":"Kirsten S","family":"Vannice","sequence":"first","affiliation":[{"name":"Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Modibo","family":"Keita","sequence":"additional","affiliation":[{"name":"Centre pour le D\u00e9veloppement des Vaccins, Minist\u00e8re de la Sant\u00e9, Bamako, Mali"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samba O","family":"Sow","sequence":"additional","affiliation":[{"name":"Centre pour le D\u00e9veloppement des Vaccins, Minist\u00e8re de la Sant\u00e9, Bamako, Mali"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna P","family":"Durbin","sequence":"additional","affiliation":[{"name":"Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad B","family":"Omer","sequence":"additional","affiliation":[{"name":"Emory Vaccine Center and Rollins School of Public Health, Emory University, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence H","family":"Moulton","sequence":"additional","affiliation":[{"name":"Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00e9n\u00e9 M","family":"Yam\u00e9ogo","sequence":"additional","affiliation":[{"name":"Institut sup\u00e9rieur des sciences de la Sant\u00e9, Universit\u00e9 Polytechnique de Bobo-Dioulasso, Burkina Faso"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick L F","family":"Zuber","sequence":"additional","affiliation":[{"name":"Department of Essential Medicines and Health Products, World Health Organization, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uma","family":"Onwuchekwa","sequence":"additional","affiliation":[{"name":"Centre pour le D\u00e9veloppement des Vaccins, Minist\u00e8re de la Sant\u00e9, Bamako, Mali"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massambou","family":"Sacko","sequence":"additional","affiliation":[{"name":"World Health Organization, Mali Country Office, Bamako, Mali"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabien V K","family":"Diomand\u00e9","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal A","family":"Halsey","sequence":"additional","affiliation":[{"name":"Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,11,9]]},"reference":[{"key":"key\n\t\t\t\t20180328155148_CIV497C1","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.vaccine.2009.11.034","article-title":"Developing sustainable funding for vaccine safety infrastructure","volume":"28","author":"Black","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180328155148_CIV497C2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0264-410X(98)00246-1","article-title":"The introduction of new vaccines into developing countries","volume":"17","author":"Mahoney","year":"1999","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180328155148_CIV497C3","doi-asserted-by":"crossref","first-page":"B108","DOI":"10.1016\/j.vaccine.2012.10.119","article-title":"Effective vaccine safety systems in all countries: a challenge for more equitable access to immunization","volume":"31","author":"Amarasinghe","year":"2013","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180328155148_CIV497C4","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/j.vaccine.2013.03.038","article-title":"Long-term safety assessment of live attenuated tetravalent dengue vaccines: deliberations from a WHO technical consultation","volume":"31","author":"Live Dengue Vaccines Technical Consultation Reporting Group","year":"2013","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180328155148_CIV497C5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1542\/peds.2008-0987","article-title":"Protecting public trust in immunization","volume":"122","author":"Cooper","year":"2008","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20180328155148_CIV497C6","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1377\/hlthaff.2011.0328","article-title":"Eliminating epidemic group A meningococcal meningitis in Africa through a new vaccine","volume":"30","author":"LaForce","year":"2011","journal-title":"Health Affairs"},{"key":"key\n\t\t\t\t20180328155148_CIV497C7","doi-asserted-by":"crossref","first-page":"A101","DOI":"10.1016\/j.vaccine.2007.04.050","article-title":"Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults","volume":"25","author":"Kshirsagar","year":"2007","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180328155148_CIV497C8","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1003812","article-title":"Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans","volume":"364","author":"Sow","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328155148_CIV497C9","doi-asserted-by":"crossref","first-page":"6456","DOI":"10.1016\/j.vaccine.2012.08.004","article-title":"Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2\u201310 years: a phase II\/III double-blind randomized controlled trial","volume":"30","author":"Hirve","year":"2012","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180328155148_CIV497C10","first-page":"29","article-title":"Global Advisory Committee on Vaccine Safety, 3\u20134 December 2009","volume":"85","author":"World Health Organization","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20180328155148_CIV497C11","first-page":"38","article-title":"Meeting of the Global Advisory Committee on Vaccine Safety, December 2010","volume":"86","author":"World Health Organization","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20180328155148_CIV497C12","first-page":"321","article-title":"Meeting of the Global Advisory Committee on Vaccine Safety, June 2011","volume":"86","author":"World Health Organization","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20180328155148_CIV497C13","article-title":"Press release: dramatic fall in cases of meningitis A in three West African nations after new vaccine introduction","author":"Meningitis Vaccine Project","year":"2011"},{"key":"key\n\t\t\t\t20180328155148_CIV497C14","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/cid\/cis892","article-title":"Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity","volume":"56","author":"Kristiansen","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328155148_CIV497C15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(13)61612-8","article-title":"Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community trial","volume":"383","author":"Daugla","year":"2013","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328155148_CIV497C16","doi-asserted-by":"crossref","first-page":"a1069","DOI":"10.1136\/bmj.a1069","article-title":"The self controlled case series method","volume":"337","author":"Whitaker","year":"2008","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180328155148_CIV497C17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","article-title":"Interaction revisited: the difference between two estimates","volume":"326","author":"Altman","year":"2003","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180328155148_CIV497C18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"RR-7","key":"key\n\t\t\t\t20180328155148_CIV497C19","first-page":"1","article-title":"Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"54","author":"Bilukha","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"key\n\t\t\t\t20180328155148_CIV497C20","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.vaccine.2012.01.027","article-title":"Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010\u20132011","volume":"30","author":"Tse","year":"2012","journal-title":"Vaccine"},{"issue":"suppl 2","key":"key\n\t\t\t\t20180328155148_CIV497C21","doi-asserted-by":"crossref","first-page":"B46","DOI":"10.1016\/j.vaccine.2011.12.112","article-title":"Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010","volume":"30","author":"Ouandaogo","year":"2012","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180328155148_CIV497C22","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1016\/j.vaccine.2012.06.006","article-title":"Monitoring adverse events following immunization with a new conjugate vaccine against group A meningococcus in Niger, September 2010","volume":"30","author":"Chaibou","year":"2012","journal-title":"Vaccine"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/61\/suppl_5\/S493\/22693246\/civ497.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T23:00:44Z","timestamp":1522278044000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/61\/suppl_5\/S493\/417552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,9]]},"references-count":22,"journal-issue":{"issue":"suppl_5","published-online":{"date-parts":[[2015,11,9]]},"published-print":{"date-parts":[[2015,11,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/civ497","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,11,15]]},"published":{"date-parts":[[2015,11,9]]}}}